Previous 10 |
home / stock / orth:cc / orth:cc news
ORTHO REGENERATIVE TECHNOLOGIES CLOSES OVERSUBSCRIBED NON-BROKERED PRIVATE PLACEMENT FOR $3.2 MILLION Canada NewsWire Proceeds to be used to accelerate the ORTHO-R Phase I/II US Clinical trial for rotator cuff tear repair Insiders contribute approxima...
ORTHO REGENERATIVE TECHNOLOGIES TO PARTICIPATE IN THE 2022 VIRTUAL GROWTH CONFERENCE PRESENTED BY MAXIM GROUP LLC AND HOSTED BY M-VEST Canada NewsWire MONTREAL , March 24, 2022 /CNW Telbec/ - Ortho Regenerative Technologies Inc. (CSE: ORTH) (OTC: ORTI...
ORTHO REGENERATIVE TECHNOLOGIES AMENDS THE TERMS OF ITS $3 MILLION NON-BROKERED PRIVATE PLACEMENT OF UNITS Canada NewsWire MONTREAL , March 21, 2022 /CNW/ - Ortho Regenerative Technologies Inc. (CSE: ORTH) (OTC: ORTIF) (" Ortho " or the " Company "), ...
ORTHO REGENERATIVE TECHNOLOGIES ANNOUNCES EXECUTIVE LEADERSHIP CHANGES Canada NewsWire Philippe Deschamps appointed President and CEO First patient enrolment into the U.S. ORTHO-R Phase I / II clinical trial still imminent. MONTREAL , ...
News, Short Squeeze, Breakout and More Instantly...
Ortho Regenerative Technologies Inc. Company Name:
ORTH:CC Stock Symbol:
CNQC Market:
Toronto, Ontario--(Newsfile Corp. - Le 7 septembre/September 2022) - Ortho Regenerative Technologies Inc. (ORTH) has announced a name and symbol change to ChitogenX Inc. (CHGX) Shares will begin trading under the new name and symbol and with a new CUSIP number on September 12, 2022. Di...
ORTHO REGENERATIVE TECHNOLOGIES ANNOUNCES CORPORATE NAME CHANGE TO CHITOGENX Canada NewsWire New Name to better represent Company's proprietary technology platform expanded applications beyond orthopedics MONTREAL , Sept. 7, 2022 /CNW Telbec/ ...
ORTHO REGENERATIVE TECHNOLOGIES ANNOUNCES ENROLLMENT OF FIRST PATIENT IN ITS U.S. PHASE I/II ROTATOR CUFF TEAR REPAIR CLINICAL TRIAL Canada NewsWire First patient surgery completed; additional surgeries already scheduled 8 clinical centres now fully initi...